High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.

High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.

View in: PubMed